Chesworth Richard
- SEC CIK
- 0001821188
No open-market purchases or sales filed in the past year.
Current role at each company
- KYMR Kymera Therapeutics, Inc.Chief Scientific Officeras of Aug 27, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Chesworth Richard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2021 (view filing) | Aug 27 | Same day | Chesworth RichardChief Scientific Officer | SSale | −33.8K | $60.12 | −$2.03M | −100.0%0 after | |
| Aug 19, 2021 (view filing) | Aug 17 | 2 days | Chesworth RichardChief Scientific Officer | SSale | −54.0K | $50.37 | −$2.72M | −100.0%0 after | 4 lots |